- Home
- LIFW vs PHIO Comparison
LIFW vs PHIO Comparison
Compare LIFW & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIFW
- PHIO
- Stock Information
- Founded
- LIFW 2014
- PHIO 2011
- Country
- LIFW United States
- PHIO United States
- Employees
- LIFW N/A
- PHIO N/A
- Industry
- LIFW Computer Software: Prepackaged Software
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- LIFW Technology
- PHIO Health Care
- Exchange
- LIFW Nasdaq
- PHIO Nasdaq
- Market Cap
- LIFW 2.8M
- PHIO 2.3M
- IPO Year
- LIFW N/A
- PHIO N/A
- Fundamental
- Price
- LIFW $0.07
- PHIO $2.21
- Analyst Decision
- LIFW
- PHIO Strong Buy
- Analyst Count
- LIFW 0
- PHIO 1
- Target Price
- LIFW N/A
- PHIO $36.00
- AVG Volume (30 Days)
- LIFW 16.3M
- PHIO 41.4K
- Earning Date
- LIFW 11-14-2024
- PHIO 11-14-2024
- Dividend Yield
- LIFW N/A
- PHIO N/A
- EPS Growth
- LIFW N/A
- PHIO N/A
- EPS
- LIFW N/A
- PHIO N/A
- Revenue
- LIFW $10,734,000.00
- PHIO N/A
- Revenue This Year
- LIFW $293,208.70
- PHIO N/A
- Revenue Next Year
- LIFW N/A
- PHIO N/A
- P/E Ratio
- LIFW N/A
- PHIO N/A
- Revenue Growth
- LIFW 217.86
- PHIO N/A
- 52 Week Low
- LIFW $0.06
- PHIO $2.17
- 52 Week High
- LIFW $7.10
- PHIO $18.81
- Technical
- Relative Strength Index (RSI)
- LIFW 27.68
- PHIO 32.01
- Support Level
- LIFW $0.08
- PHIO $2.49
- Resistance Level
- LIFW $0.20
- PHIO $3.70
- Average True Range (ATR)
- LIFW 0.03
- PHIO 0.31
- MACD
- LIFW -0.00
- PHIO -0.10
- Stochastic Oscillator
- LIFW 8.49
- PHIO 2.75
About LIFW MSP Recovery Inc.
MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.